Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,259,605
-
Share change
-
+1,470,129
-
Total reported value
-
$179,187,359
-
Price per share
-
$13.52
-
Number of holders
-
52
-
Value change
-
+$19,876,000
-
Number of buys
-
2
Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q4 2013
As of 31 Dec 2013,
TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,259,605 shares.
The largest 10 holders included
Broadfin Capital, LLC, FMR LLC, WELLINGTON MANAGEMENT CO LLP, Novo A/S, Flagship Ventures 2007 General Partner LLC, MARXE AUSTIN W & GREENHOUSE DAVID M, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, and HARVEY CAPITAL MANAGEMENT INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.